Alleghany Corporation’s Eli Lilly LLY Stock Holding History

Alleghany Corporation’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-50,000	Closed	-$3.63M	–	48
2015 Q1	$3.63M	Sell	50,000 -1,507,000	-97%	-$107M	0.13%	27
2014 Q4	$107M	Hold	1,557,000	–	–	4.19%	8
2014 Q3	$101M	Buy	1,557,000 +7,000	+0.5%	+$443K	3.78%	11
2014 Q2	$96.4M	Buy	1,550,000 +300,000	+24%	+$17.9M	3.49%	13
2014 Q1	$73.6M	Buy	1,250,000 +450,000	+56%	+$25.1M	3.01%	16
2013 Q4	$40.8M	Buy	800,000 +750,000	+1,500%	+$37.6M	2%	23
2013 Q3	$2.52M	Hold	50,000	–	–	0.13%	38
2013 Q2	$2.46M	Buy	+50,000	New	+$2.72M	0.14%	32

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Alleghany Corporation's LLY Position: Q2 2015 in Review

Alleghany Corporation sold out of Eli Lilly (LLY) in Q2 2015, closing a stake of 50,000 shares — an estimated $3.63M sold.

Alleghany Corporation first reported a position in LLY in Q2 2013 and held it in 8 quarters. The position peaked at $107M in Q4 2014. 1,139 funds tracked by Wall St. Rank hold LLY as of Q2 2015.

Alleghany Corporation reported no remaining Eli Lilly position as of Q2 2015 after selling out during the quarter.
Alleghany Corporation sold 50,000 Eli Lilly shares in Q2 2015, an estimated $3.63M.
Alleghany Corporation first reported a position in Eli Lilly in Q2 2013 and held it in 8 quarters.
Alleghany Corporation's Eli Lilly position peaked at $107M in Q4 2014.
1,139 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2015.

Based on Alleghany Corporation's 13F filing for Q2 2015, filed 5 Aug 2015.